PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,875 | +30.1% | 59,067 | +5.4% | 0.00% | – |
| Q2 2023 | $64,458 | +30.5% | 56,050 | +20.3% | 0.00% | – |
| Q1 2023 | $49,382 | -21.4% | 46,587 | +12.8% | 0.00% | – |
| Q4 2022 | $62,788 | -28.3% | 41,308 | 0.0% | 0.00% | – |
| Q3 2022 | $87,573 | +78.7% | 41,308 | +13.9% | 0.00% | – |
| Q2 2022 | $49,000 | -36.4% | 36,274 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -43.0% | 36,274 | 0.0% | 0.00% | – |
| Q4 2021 | $135,000 | -27.0% | 36,274 | -2.1% | 0.00% | – |
| Q3 2021 | $185,000 | -23.2% | 37,036 | 0.0% | 0.00% | – |
| Q2 2021 | $241,000 | +14.8% | 37,036 | +21.6% | 0.00% | – |
| Q1 2021 | $210,000 | -28.3% | 30,460 | +6.0% | 0.00% | -100.0% |
| Q4 2020 | $293,000 | +253.0% | 28,723 | +20.7% | 0.00% | – |
| Q3 2020 | $83,000 | -33.6% | 23,791 | -5.3% | 0.00% | – |
| Q2 2020 | $125,000 | +3.3% | 25,133 | -29.4% | 0.00% | – |
| Q1 2020 | $121,000 | – | 35,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |